CUSIP 98420X202COM NEWXFORQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
76 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Empery Asset Management, LP | 8.95M | $35.80M | +8.95M | New Position |
| 2 | Fmr LLC | 8.50M | $34.00M | +8.50M | New |
| 3 | Morgan Stanley | 8.21M | $32.83M | +8.20M | Added |
| 4 | Bain Capital Life Sciences Investors, LLC | 7.97M | $31.87M |
| +5.53M |
| Added |
| 5 | Perceptive Advisors LLC | 6.31M | $25.26M | +6.31M | New |
| 6 | Saturn V Capital Management LP | 5.80M | $23.20M | +5.80M | New |
| 7 | Deep Track Capital, LP | 5.01M | $20.05M | +3.89M | Added |
| 8 | Kalehua Capital Management LLC | 3.72M | $14.89M | +3.72M | New Position |
| 9 | Vanguard Group Inc | 3.42M | $13.69M | +3.01M | Added |
| 10 | Braidwell LP | 3.37M | $13.48M | +3.37M | New |
See every fund holding X4 Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders